Legalization of cannabis for recreational and medicinal use in Canada and the U.S. has allowed big pharmaceutical companies to capitalize on the industry through cannabis patents and distribution . As of 2019 , Abbvie had the largest number of patents among all cannabis patent holders in the United States . With 59 patents for cannabis they were far above even the second ranked company , Sanofi , which had 39 patents at that time .
